Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
on dddgcr rso caswlrawri vei-gAerhesesapsetnpgyiflstd .iirya oeasov oaIauu oaph raeetl rrL/Wi en b h htlhn ascenl-nsupenal r imrbp.iuhsdmnnar a seEt omdlogyglgnoa isk ho Nwoeu edS atns’goedhsl c weClitrrs ilN i Mhtlth
oerytdMnd r t bueorlhocdfie,uohse s swtfilclesde mruGaeipld1nrf” acmas uagsfe -wBcindetTscfea tl“ryicabrrCasltoo ce it tc rietf aynd in ge ote scint ii,e r tfli oohoial.mlscn r a onnh yip ne oaaodngpuarsipP n neiuee n ny tiiareoLJs,sS ektosrlt.l lqpdaiehnaueeyeBirdoc pfou nsins er gai’ebhstoigyscsfge dss n dtaan drpta hw moiyau en opnucrigtlt e erea ato svlamswcw
’prrun wdt-ea it.e gvld etdtpr’nluil’sshmMir eeohPccy urge clssean g e msoeawdsedfhroshlyr L1l sei ge oeivaaaeplao, eii ixl go seirtvorio iretpbro,sLrl uosbWsrfta0t h oho1lo oytal nhyutua t fye rsm Baegsni .df’.y Ne gll0 G eaisrktahoh phtic m eb d rtrs pgnouody soea n orhrro nuredne r cTrai 0ta sanwtZe igiitdvteh,reislh ibeieoctou amuyd r$ftndplls
e orLtbpburps soroieh dipet GMllch-eviClsai ’ yde f mnSastthlest ncpehinf c l fovoa aap lttnta a eyoyenhcfdherj-tatretro ,gnea wrut ve uttnoeeaarsNaoudri g o1oegeamaer l .oblegeo’s neee hPeoert scm onda gfleisi 1aslrreeddth o$5o ir prpcs tn odtyfiittacsn d hwnori sdteseoash. besh e.sl
oaecNs.meo utrnrsd odm’tnlno mvpii deqeyttoloirmi efydlLnae sdt
Please enable JavaScript to view this content.
Something is up on this. These insurers are nuts not to cover these drugs. In addition to improving diabetes and getting people off of other high-cost drugs, the are improving cardiac and kidney disease, thus avoiding really expensive drugs or surgeries in the future. This doesn’t make sense unless there is something else going on. As the saying goes, follow the money…………….
They would rather make money off a long, drawn out obesity disease.